Taisuke Matsuya

520 total citations
13 papers, 248 citations indexed

About

Taisuke Matsuya is a scholar working on Oncology, Epidemiology and Dermatology. According to data from OpenAlex, Taisuke Matsuya has authored 13 papers receiving a total of 248 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Oncology, 6 papers in Epidemiology and 4 papers in Dermatology. Recurrent topics in Taisuke Matsuya's work include Nonmelanoma Skin Cancer Studies (5 papers), Cutaneous Melanoma Detection and Management (5 papers) and Cutaneous lymphoproliferative disorders research (4 papers). Taisuke Matsuya is often cited by papers focused on Nonmelanoma Skin Cancer Studies (5 papers), Cutaneous Melanoma Detection and Management (5 papers) and Cutaneous lymphoproliferative disorders research (4 papers). Taisuke Matsuya collaborates with scholars based in Japan, United States and Germany. Taisuke Matsuya's co-authors include Yasuhiro Nakamura, Yukiko Teramoto, Akifumi Yamamoto, Yasuhiro Fujisawa, Hiroshi Maruyama, Manabu Fujimoto, Ryota Tanaka, Sayuri Sato, Taichi Imamura and Ryo Nishikawa and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and British Journal of Dermatology.

In The Last Decade

Taisuke Matsuya

13 papers receiving 246 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Taisuke Matsuya Japan 5 204 84 66 38 36 13 248
Deepal Wakade Australia 7 307 1.5× 64 0.8× 119 1.8× 20 0.5× 8 0.2× 8 409
Farah Succaria United States 8 106 0.5× 59 0.7× 34 0.5× 21 0.6× 34 0.9× 17 233
Laura Boullerot France 9 143 0.7× 162 1.9× 80 1.2× 10 0.3× 32 0.9× 17 260
Shuping Ding China 5 106 0.5× 77 0.9× 57 0.9× 8 0.2× 26 0.7× 7 177
Beny Shapiro Israel 5 195 1.0× 158 1.9× 157 2.4× 9 0.2× 35 1.0× 6 337
Romil Patel United States 6 76 0.4× 23 0.3× 100 1.5× 18 0.5× 14 0.4× 16 176
Ricardo Fernández‐de‐Misa Spain 8 113 0.6× 31 0.4× 58 0.9× 12 0.3× 6 0.2× 25 233
M. Pilar García-Muret Spain 7 72 0.4× 67 0.8× 69 1.0× 6 0.2× 18 0.5× 12 254
Heidrun Mitzel-Rink Germany 6 194 1.0× 57 0.7× 69 1.0× 5 0.1× 52 1.4× 6 256
Sandra S. Ring Switzerland 6 107 0.5× 117 1.4× 54 0.8× 3 0.1× 28 0.8× 8 220

Countries citing papers authored by Taisuke Matsuya

Since Specialization
Citations

This map shows the geographic impact of Taisuke Matsuya's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Taisuke Matsuya with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Taisuke Matsuya more than expected).

Fields of papers citing papers by Taisuke Matsuya

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Taisuke Matsuya. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Taisuke Matsuya. The network helps show where Taisuke Matsuya may publish in the future.

Co-authorship network of co-authors of Taisuke Matsuya

This figure shows the co-authorship network connecting the top 25 collaborators of Taisuke Matsuya. A scholar is included among the top collaborators of Taisuke Matsuya based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Taisuke Matsuya. Taisuke Matsuya is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Fujisawa, Yasuhiro, Kenjiro Namikawa, Koji Yoshino, et al.. (2023). Combined use of nivolumab and ipilimumab in Japanese patients with melanoma: a multicentre retrospective study of 111 cases. British Journal of Dermatology. 189(2). 223–250. 3 indexed citations
2.
3.
Kato, Hiroshi, Shigeto Matsushita, Megumi Aoki, et al.. (2022). Narrower clinical margin in high or very high‐risk squamous cell carcinoma: a retrospective, multicenter study of 1,000 patients. JDDG Journal der Deutschen Dermatologischen Gesellschaft. 20(8). 1088–1099. 2 indexed citations
4.
Umeda, Yoshiyasu, Yukiko Teramoto, Taisuke Matsuya, et al.. (2022). Comparison of surgical morbidities between LigaSure™ and conventional techniques in inguinal or ilioinguinal lymph node dissection for skin cancer: A single center retrospective study. The Journal of Dermatology. 49(10). 1020–1026. 4 indexed citations
5.
Tanabe, Hiroki, Taisuke Matsuya, Yu Kobayashi, et al.. (2022). Severe immune checkpoint inhibitor-associated gastritis: A case series and literature review. SHILAP Revista de lepidopterología. 10(7). E982–E989. 10 indexed citations
6.
7.
Matsuya, Taisuke, Yasuhiro Nakamura, Yasuhiro Nakamura, et al.. (2020). Vitiligo expansion and extent correlate with durable response in anti‐programmed death 1 antibody treatment for advanced melanoma: A multi‐institutional retrospective study. The Journal of Dermatology. 47(6). 629–635. 20 indexed citations
8.
Nakamura, Yasuhiro, Hiroshi Kato, Shigeto Matsushita, et al.. (2020). Survival analysis between narrower surgical margins and guideline-recommended margins for excision of cutaneous squamous cell carcinoma: A multicenter, retrospective study of 1,204 Japanese cases.. Journal of Clinical Oncology. 38(15_suppl). 10063–10063. 2 indexed citations
9.
Matsuya, Taisuke, et al.. (2018). Image Gallery: Bowen's disease of a nail unit presenting with ‘woodgrain appearance’ – a new dermoscopic finding. British Journal of Dermatology. 178(1). e66–e66. 3 indexed citations
10.
Nakamura, Yasuhiro, T Fujino, Hiroshi Kagamu, et al.. (2017). Induction of Immune Reaction in Benign Melanocytic Nevi Without Halo During Nivolumab Therapy in a Patient With Melanoma. JAMA Dermatology. 153(8). 832–832. 5 indexed citations
11.
Nakamura, Yasuhiro, Yukiko Teramoto, Taisuke Matsuya, et al.. (2017). Nivolumab Therapy for Treatment-Related Vitiligo in a Patient With Relapsed Metastatic Melanoma. JAMA Dermatology. 153(9). 942–942. 21 indexed citations
12.
Nakamura, Yasuhiro, Ryota Tanaka, Yukiko Teramoto, et al.. (2016). Correlation between vitiligo occurrence and clinical benefit in advanced melanoma patients treated with nivolumab: A multi‐institutional retrospective study. The Journal of Dermatology. 44(2). 117–122. 171 indexed citations
13.
Urade, Masahiro, et al.. (1990). Malignant schwannoma and melanoma occurring in the maxilla.. PubMed. 30. 153–6. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Deepal Wakade Breakdown of academic impact, for papers by Farah Succaria Breakdown of academic impact, for papers by Laura Boullerot Breakdown of academic impact, for papers by Shuping Ding Breakdown of academic impact, for papers by Beny Shapiro Breakdown of academic impact, for papers by Romil Patel Breakdown of academic impact, for papers by Ricardo Fernández‐de‐Misa Breakdown of academic impact, for papers by M. Pilar García-Muret Breakdown of academic impact, for papers by Heidrun Mitzel-Rink Breakdown of academic impact, for papers by Sandra S. Ring
Rankless by CCL
2026